It also delays the digestion process in the stomach
Risks of Extended GLP-1 Use The risks of extended GLP-1 use are still being studied, and while many people use them safely, potential concerns include: Digestive issues Some patients may experience ongoing nausea, constipation, or discomfort
Choosing the right peptide, or the correct combination, requires an understanding of how they function at a cellular level 1
Need medical legitimacy and approved-label pathways
Clinical trials are the main structured pathway for investigational medicines
Further, one trial, conducted in obese patients with chronic obstructive pulmonary disease, reported an average weight loss of 8.2kg after 20 weeks of 3.0mg liraglutide daily administration [13]